PDS Biotechnology PDSB
NASDAQ PDSB
$1.02 -0.01 (-0.97%)
At close: Nov 11, 2026 · 4:00 PM EST

PDS Biotechnology (PDSB) Other Non-Current Liabilities (2014 - 2026)

Updated

PDS Biotechnology's Other Non-Current Liabilities was $291,225 in Q4 2018.

Analysis

PDS Biotechnology (PDSB) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

  • Other Non-Current Liabilities shows a four-year compound annual growth rate of -35.4% (FY2014 to FY2018).
  • In earlier years, Other Non-Current Liabilities was $1.67 million in FY2014.
  • The Q4 2018 figure marks the highest quarterly Other Non-Current Liabilities since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PDS Biotechnology 57.60 Mn -22.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 370.00
Dec 31, 2025 368.00
Mar 31, 2025 368.00
Dec 31, 2024 368.00
Sep 30, 2024 368.00
Jun 30, 2024 368.00
Mar 31, 2024 368.00
Mar 31, 2023 3,343.00
Dec 31, 2018 291,225.00
Sep 30, 2018 31,925.00
Dec 31, 2017 25,000.00
Jun 30, 2016 28,627.00
Mar 31, 2016 31,849.00
Sep 30, 2015 3.73 Mn
Dec 31, 2014 1.67 Mn
API Access

PDS Biotechnology Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PDSB&period=max&api_key=YOUR_API_KEY